Despite confirmation of a link between routine Pap smear screening and a lower risk of developing cervical cancer in women older than 65 years, most US health guidelines discourage older women from undergoing routine Pap smears unless they have pre-existing risk factors.
Offering free pap smears for cervical cancer screening did not increase pap smear frequency in low income women, even though low income and socioeconomic status are more likely to predict women skipping pap smears.
Adherence to cancer screening recommendations was not found to vary by race/ethnicity and body weight/obesity. In a focused look at the influence of body mass index (BMI) as a measure of obesity, some screening disparities may be decreasing.
Sign Up for Free e-newsletters
- Smoking Ups Risk of Myeloproliferative Neoplasms Overall and by Subtype
- Myelofibrosis: From Diagnosis to Early Intervention
- FDA Approves HPV Vaccine for People Through Age 45
- HPV Vaccination and Anti-programmed Cell Death 1 Inhibition Improve Survival in Patients With Invasive HPV-16
- Use of Corticosteroids With PD-1 or PD-L1 Inhibitors Associated With Poorer Outcomes in NSCLC
- Anxiety, Depression in Prostate Cancer: Managing Psychosocial Effects in Male Patients
- Tandem Autologous-Allogenic HCT Offers Long-Term Remission in Multiple Myeloma
- Tool Addresses Well-being of Informal Caregivers of Patients With Cancer
- Hematologic Cancers: 8 Tips Oncology Nurses Should Share with Caregivers
- Navigation at the End of Therapy: A Crucial Transition in Lymphoma Treatment
- Strength and Hope for Women in the Mist of Cancer
- Prospective Study Measures Cognitive, Treatment Effects in Older Breast Cancer Survivors
- Immune Checkpoint Inhibitor Therapy May Affect Thyroid Function
- Hypofractionated Radiotherapy After Conservative Surgery May Increase Low-intermediate Grade Late Fibrosis in Breast Cancer Patients
- Should Increased Breast Density Dictate More Breast Cancer Screenings?
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|